$ZyVersa Therapeutics (ZVSA.US)$ "The anticipation of an Investigational New Drug (IND) filing for IC 100 in 2024 further supports the positive outlook, marking a major milestone for the program.
Additionally, Arce’s confidence is backed by the near-term initiation of a Phase 2a trial of another ZyVersa candidate, VAR 200, in patients with diabetic kidney disease, which represents a significant step forward for the company.
These milestones affirmed buy rating for the company's stocks".
tipranks.com/ne...

$TCTM Kids IT Education (TCTM.US)$ to $2 go go go

$Alibaba (BABA.US)$ dont worry guys, it sure will bounce back again. hold it for now. they will announce repurchase plan in early April. be patient and wait

$Baidu (BIDU.US)$ earning report released on 28/2, better stock up now. learnt from the meta stock